(NYSEMKT: VNRX) Volitionrx's forecast annual revenue growth rate of 97.21% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.45%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.65%.
Volitionrx's revenue in 2026 is $3,444,643.On average, 7 Wall Street analysts forecast VNRX's revenue for 2026 to be $92,696,978, with the lowest VNRX revenue forecast at $82,232,936, and the highest VNRX revenue forecast at $103,449,683. On average, 6 Wall Street analysts forecast VNRX's revenue for 2027 to be $2,043,302,631, with the lowest VNRX revenue forecast at $319,081,111, and the highest VNRX revenue forecast at $5,207,484,561.
In 2027, VNRX is forecast to generate $327,380,179 in revenue, with the lowest revenue forecast at $123,764,357 and the highest revenue forecast at $541,460,042.